Testing reveals popular weight loss peptide had double the strength on label

A recent test found that a widely used, but unapproved, weight loss peptide called retatrutide contains double the amount of active ingredient listed on its label, prompting doctors to issue a serious warning about overdose risks. This revelation underscores the dangers of using unapproved health products, as their actual contents can differ significantly from what's advertised. The implications are significant, as misuse of such peptides could lead to severe health complications, highlighting the need for stricter regulation and oversight in the supplement industry.